Levovent (Formoterol Fumarate)

Formoterol fumarate works by selectively stimulating β2‑adrenergic receptors on airway smooth‑muscle cells. This activation increases cyclic AMP levels, leading to relaxation of the smooth muscle and inhibition of inflammatory mediator release, which together produce a sustained bronchodilatory effect.

The dose of Levovent is individualized by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. The prescriber determines the appropriate inhalation frequency and strength, and patients should follow the specific instructions provided on the prescription label.

Safety data for formoterol fumarate during pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Levovent with their physician before starting treatment.

To order Levovent, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Levovent (formoterol) offers a rapid onset of action within minutes and a duration of up to 12 hours, similar to other long‑acting β2‑agonists such as salmeterol. Compared with short‑acting bronchodilators, it provides sustained control but is not intended for acute symptom relief. Combination inhalers that pair a LABA with an inhaled corticosteroid are often used for step‑up therapy in asthma and COPD.

Levovent should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and heat. Keep the inhaler device upright and avoid exposing it to direct sunlight. Do not freeze the product, and replace the inhaler after the recommended number of doses or when the dose counter indicates it is empty.

Levovent is delivered via an inhalation device. The patient should exhale fully, place the mouthpiece in the mouth, and inhale slowly and deeply while actuating the device as instructed. After inhalation, the patient should hold their breath for a few seconds to allow optimal drug deposition, then breathe out gently. Proper technique should be reviewed by a healthcare professional.

Serious risks associated with Levovent include paradoxical bronchospasm, which can cause sudden worsening of breathing, and cardiac arrhythmias such as tachycardia or palpitations. Rarely, severe allergic reactions (anaphylaxis) may occur. Patients should seek immediate medical attention if they experience sudden breathlessness, chest pain, irregular heartbeat, or signs of an allergic reaction.

Levovent should be avoided in individuals with known hypersensitivity to formoterol fumarate or any component of the inhaler. It is also contraindicated in patients who have experienced a severe paradoxical bronchospasm with a β2‑agonist. Caution is advised for patients with uncontrolled cardiovascular disease, and the drug should be used only under medical supervision in such cases.